-+ 0.00%
-+ 0.00%
-+ 0.00%

Radiopharm reports 90% primary-endpoint concordance in second interim analysis of RAD 101 Phase 2b brain metastases imaging trial

Reuters·03/24/2026 11:00:59

Please log in to view news